BOSTON, December 17, 2018 – Improving the quality of critical care has always been their top priority but earning accolades along the way is an added bonus. In 2018, Etiometry earned major recognition and funding from prestigious organizations nearby and nationally.
Competing against 213 companies from five of the six New England states can be a daunting task for any businessowner; but Etiometry was up for the challenge. After narrowing the competition to 50 semi-finalists, then 20 finalists, Etiometry’s CEO Evan Butler presented the company’s mission in front of a 64-judge panel. Several months of deliberation went by but, ultimately, Etiometry took top honors as one of the eight winners of the 2018 New England Business Association’s Innovation Awards. “As the Circle of Excellence welcomes the class of 2018, I can honestly say it is one of our best yet”, said New England Innovation Awards Committee Chairman, Todd Faber, President, The Faber Group, in a press release.
The largest source of funding for medical research in the world continues to see value in Etiometry’s work. For the third time in four years, The National Institutes of Health awarded Etiometry nearly one million dollars to continue their groundbreaking progress in advanced analytics for critical care facilities. The latest grant award aims to investigate how Etiometry’s FDA cleared Risk Analytics Algorithm for Inadequate Delivery of Oxygen, known as the IDO2 Index, can best be used to inform treatment decisions. With the help of their clinical partners, the team is designing and deploying protocols and studying their critical care outcomes; such as length of stay, time on ventilation, and ECMO events. As a Boston-based company, Etiometry is proud to contribute to the city’s unparalleled 23-year record for most NIH funds.
Etiometry provides next-generation patient monitoring software for hospital ICUs. By consolidating data from many ICU devices, the Etiometry Platform helps clinicians better understand the trajectory of their patients by viewing salient clinical information on a single screen. It fosters more objective communication among care teams and provides a common platform to analyze the best course of treatment for ICU patients. For more information, visit www.etiometry.com.